SCHEMBL1997712

SCHEMBL1997712

CN1CCN2CCC(n3nc(C4=C(c5c[nH]c6sccc56)C(=O)NC4=O)c4ccccc43)CC2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 17/20 0.42
PRKCD Q05655 17/20 0.42
PRKCB P05771 17/20 0.42
PRKCE Q02156 16/20 0.42
PRKCH P24723 16/20 0.42
CAMK2D Q13557 5/20 0.42
PRKCG P05129 5/20 0.42
PRKCZ Q05513 4/20 0.42
CAMK2B Q13554 4/20 0.42
CAMK2G Q13555 4/20 0.42
CAMK2A Q9UQM7 4/20 0.42
SRC P12931 2/20 0.42
PRKACA P17612 1/20 0.39
PRKACG P22612 1/20 0.39
PRKACB P22694 1/20 0.39
PRKCQ Q04759 13/20 0.38
GSK3B P49841 3/20 0.38
PDPK1 O15530 1/20 0.38
DYRK3 O43781 1/20 0.38
PRKD3 O94806 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1990972 0.89 PRKCB (0.51) PRKCAPRKCDPRKCBPRKCEPRKCH
SCHEMBL1996632 0.88 PRKCH (0.43) PRKCAPRKCDPRKCBPRKCEPRKCH
SCHEMBL1995932 0.88 PRKCA (0.37) PRKCAPRKCDPRKCBPRKCEPRKCH
SCHEMBL1993469 0.88 PRKCB (0.38) PRKCAPRKCDPRKCBPRKCEPRKCH
SCHEMBL1991052 0.85 PRKCB (0.58) PRKCAPRKCDPRKCBPRKCEPRKCH
SCHEMBL1991015 0.83 PRKCA (0.41) PRKCAPRKCDPRKCBPRKCEPRKCH
SCHEMBL1991764 0.82 CAMK2D (0.44) PRKCAPRKCDPRKCBPRKCEPRKCH
SCHEMBL1994823 0.82 PRKCA (0.43) PRKCAPRKCDPRKCBPRKCEPRKCH
SCHEMBL1991096 0.81 PRKCA (0.39) PRKCAPRKCDPRKCBPRKCEPRKCH
SCHEMBL1997672 0.81 PRKACA (0.43) PRKCAPRKCDPRKCBPRKCEPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO PRKCA 3438/4885PRKCD 2857/4885PRKCB 3335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.